Potential Immune Microenvironment Biomarkers in SCLC: J-TAIL-2 Observational Study

Masayuki Shirasawa(National Cancer Center Hospital East), Akihiko Gemma(Nippon Medical School)

JTO Clinical and Research Reports

October 30, 2025

10.1016/j.jtocrr.2025.100926

Cited by 0

Related Papers

MiR-134/487b/655 Cluster Regulates TGF-β–Induced Epithelial–Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting <i>MAGI2</i> in Lung Adenocarcinoma Cells

|Molecular Cancer Therapeutics|2013|186

MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells

|International Journal of Oncology|2012|169

miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells

|International Journal of Oncology|2016|83

Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer

|Scientific Reports|2018|56

Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancer

|Oncotarget|2018|42